Clinical Trial Update: Dalpiciclib Plus Letrozole and Capecitabine [Phase 2]

View source ↗

Summary

Phase 2 trial update of dalpiciclib in combination with letrozole and capecitabine for advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Dalpiciclib (dalpiciclib)
• Letrozole (letrozole)

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Advanced Breast Cancer | Phase 2 | Status: UNKNOWN